Table 1.
Vehicle | Targeted miRNA | Antagonist or mimics |
Model | Effect | Reference |
---|---|---|---|---|---|
Local Delivery | |||||
Cholesterol-conjugated 2′-O- methyl-modified |
miR-375 | Mimics | Hepatoma xenograft | Inhibition of tumor growth | [94] |
Lentiviral vector | let-7 | Mimics | Non-small-cell lung cancer (NSCLC) | Inhibition of the growth of K-ras-dependent lung tumors | [95] |
Polyethyleneimine (PEI) | miR-145 miR-33a |
Mimics | Colon carcinoma xenograft | Induction of apoptosis, inhibition of tumor growth and downregulation of the oncogenic kinase Pim-1 |
[96] |
Systemic delivery | |||||
Seed-targeting tiny LNAs | miR-21 | Antagonist | Breast cancer | Repression of the miR-21 function in tumor | [106] |
Cationic liposomes | miR-143 | Mimics | Colorectal carcinoma | Inhibition of tumor growth | [109] |
Lentiviral vectors | miR-15a/16 | Mimics | Chronic lymphocytic leukemia | Restoration of miR-15a/16 expression and inhibition of tumor cell proliferation |
[110] |
miR-494 | Antagonist | Breast cancer | Inhibition of tumor growth and metastasis | [111] | |
Adeno-associated viruses (AAVs) |
miR-26a | Mimics | Hepatocellular carcinoma | Inhibition of tumor cell proliferation and induction of apoptosis | [112] |
Silica nanoparticles | miR-34a | Mimics | Neuroblastoma | Induction of apoptosis, reduction in vascular density of tumors and inhibition of tumor growth |
[101] |
PEGylated-PLGA | miR-21 | Antagonists | Breast cancer | Efficient delivery of antagomiR-21 and prolonged release | [125] |
PLGA-penetratin | miR-155 | Antagonists | Lymphoma | Induction of apoptosis and reduction of tumor growth | [126] |
PEI | miR-145 miR-33a |
Mimics | Colorectal carcinoma | Reduction of tumor cell proliferation and tumor growth | [130] |
LNP-DP1 | miR-122 | Mimics | Hepatocellular carcinoma | Inhibition of angiogenesis and tumor growth | [132] |
Cationic DOTMA lipoplexes | miR-133b | Mimics | NSCLC | Increased expression of miR-133b and downregulation of prosurvival gene MCL-1 |
133] |
miR-29b | Mimics | NSCLC | Reduced expression of the key target oncogenes and inhibition of tumor growth |
[134] | |
Neutral lipid | miR-34a | Mimics | NSCLC | Inhibition of tumor growth | [136] |
miR-34a let-7 |
Mimics | NSCLC | Inhibition of tumor cell proliferation and induction of apoptosis | [137] | |
LPH-PEG-GC4 | miR-34a | Mimics | Lung cancer | Reduction of tumor growth, induction of apoptosis, inhibition of survivin expression and downregulation of pathway |
[102] |